Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep1010 | Pituitary - Clinical | ECE2017

Hypertension, acromegaly and pegvisomant treatment: Experience from ACROSTUDY

Vila Greisa , Jan vanderLely Arrt , Neggers Sebastian , Luger Anton , Webb Susan , Biller Beverly , Jonsson Peter , Hey-Hadavi Judith

Introduction: Hypertension (HTN) is a major cardiovascular (CV) risk factor and independent predictor of the increased mortality in patients with acromegaly. Surgical cure of acromegaly is associated with improvement in blood pressure (BP) levels, however little is known on the effect of pegvisomant (PEGV) treatment on HTN.Methods/design: ACROSTUDY is an open-label, international, prospective, non-interventional study monitoring the long-term safety of P...